미국의 행동 건강 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the u.S. behavioral health market size is projected to be USD 76.25 billion in 2025, USD 79.79 billion in 2026, and reach USD 100.15 billion by 2031, growing at a CAGR of 4.65% from 2026 to 2031.

This report is Segmented by Treatment Modality (Ambulatory Visits, Prescription Medicines, Other Services), Condition Group (Mental Health Conditions, Substance Use Disorders, Co-Occurring Conditions), Site of Care (Outpatient, Partial Hospitalization/IOP, Inpatient, Residential, Others), and Age Cohort (Children, Adolescents, Adults, Geriatric). Market Forecasts are Provided in Terms of Value (USD).

U.S. Behavioral Health Market Trends and Insights

Tightening Parity Enforcement Reshapes Reimbursement and Network Adequacy

State and federal parity enforcement is transforming compliance into a revenue-critical issue for the United States behavioral health market. In 2024 and 2025, Georgia imposed nearly USD 25 million in fines on 22 insurers for non-quantitative treatment limitations, while Washington fined Kaiser Foundation Health Plan USD 300,000, and Regence BlueShield and Premera Blue Cross USD 550,000 each for similar violations. Payers are expanding provider networks and improving outpatient reimbursements to reduce regulatory scrutiny. Although the 2024 MHPAEA Final Rule adopted a federal non-enforcement stance in May 2025, states like Washington, Colorado, Maryland, and California incorporated its provisions into state laws, maintaining compliance expectations in major commercial markets. This state-level adoption establishes a national baseline for access and documentation standards, ensuring providers who meet these criteria benefit from higher reimbursement quality.

Medicare and Medicaid Coverage Expansion Unlocking Access at Mid-Acuity Levels

Coverage expansions are addressing gaps in the United States behavioral health market, particularly for care levels between outpatient visits and inpatient services. Medicare began covering intensive outpatient program services on January 1, 2024, under the Consolidated Appropriations Act, 2023, enabling over 60 million beneficiaries to access reimbursable mid-acuity care. Geographic restrictions for behavioral health telehealth were permanently removed, allowing beneficiaries to receive care at home beyond the 2027 general telehealth deadline. Medicaid has also expanded Certified Community Behavioral Health Clinics from 67 facilities in 8 states in 2017 to over 500 across 46 states and the District of Columbia. By FY2025, 19 states recognized CCBHCs as Medicaid providers. The CMS ACCESS behavioral health model, launching in July 2026 with 85 behavioral health organizations and major payer alignment, strengthens outcome-linked payment systems and supports scalable mid-acuity care pathways.

Workforce Shortages and Low Public-Payer Reimbursement Rates

Workforce shortages remain a significant barrier in the United States behavioral health market. By December 2025, 137 million Americans, or 40% of the population, lived in federally designated mental health professional shortage areas, with the number of such designations increasing from 6,418 in 2024 to 6,807 in 2026. By 2038, projected shortfalls include 99,840 mental health counselors, 99,840 psychologists, 77,050 addiction counselors, and 36,780 adult psychiatrists. The supply of psychiatrists is expected to decline from 37,470 in 2026 to 36,550 in 2038, even as annual demand rises by 40.7%. Rural areas face significant access challenges, with rural counties nearly three times more likely than urban ones to lack psychologists, and 22% of rural counties reporting no clinical social workers.

Other drivers and restraints analyzed in the detailed report include:

1. Persistent Unmet Demand in Co-occurring Mental Health and SUD Conditions
2. Sustained Tele-buprenorphine and Controlled-Substance Telehealth Prescribing
3. Ghost Networks, Prior Authorization Friction, and Utilization Management Barriers

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

In 2025, ambulatory visits accounted for 41.10% of the United States behavioral health market, leading as care shifted toward outpatient and virtual settings. Behavioral health made up 65.6% of all United States telehealth visits in 2024, a significant rise from 18.4% in 2018. Total behavioral health telehealth visits reached 66.4 million, surpassing the 62.8 million primary care telehealth visits during the same period. This shift highlights telehealth's evolution into a standard delivery channel for routine therapy, medication management, and follow-ups.

Prescription medicines are the fastest-growing treatment modality, with the United States behavioral health market for this segment projected to grow at a 5.25% CAGR from 2026 to 2031. Stimulant prescriptions rose by 53.3% between 2018 and 2024, while antipsychotic volumes increased by 45.4%. Nurse practitioners and physician assistants managed 34.3% of prescription volume in 2024, surpassing psychiatrists and primary care physicians.

Mental health conditions held a 72.2% share in 2025, making them the largest condition group in the United States behavioral health market. Anxiety disorders led telehealth use among Medicare beneficiaries in 2024, with 9.45 million visits, followed by 8.77 million visits for depressive disorders. Substance use disorders remain smaller but are growing due to contingency management programs supported by Medicaid Section 1115 waivers in several states. Co-occurring conditions are the fastest-growing segment, with a projected 5.95% CAGR from 2026 to 2031. A 2026 study demonstrated that integrated buprenorphine and psychotherapy significantly improved remission rates, reinforcing the value of combined care for dual-diagnosis populations.

List of Companies Covered in this Report:

1. Acadia Healthcare Company, Inc.
2. Behavioral Health Group
3. Boulder Care
4. Brightside Health, Inc.
5. Charlie Health
6. Eleanor Health
7. Hazelden Betty Ford Foundation
8. Headway
9. LifeStance Health Group, Inc.
10. Lyra Health, Inc.
11. Newport Healthcare
12. Oceans Healthcare
13. Pyramid Healthcare
14. Rogers Behavioral Health
15. Rula Health
16. Sheppard Pratt
17. Spring Health
18. Talkspace, Inc.
19. Teladoc Health, Inc. / BetterHelp
20. Universal Health Services

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Tightening Parity Enforcement and Network Accountability
  • 4.2.2 Medicare and Medicaid Coverage Expansion for Behavioral Clinicians
  • 4.2.3 Persistent Unmet Demand in Co-Occurring Mental Health and SUD Care
  • 4.2.4 Sustained Tele-Buprenorphine and Controlled-Substance Telehealth Flexibility
  • 4.2.5 Shift From Cash-Pay Point Solutions Toward Payer-Embedded Behavioral Care
  • 4.2.6 Measurement-Based Care and AI-Enabled Operating Leverage in Outpatient Platforms
• 4.3 Market Restraints
  • 4.3.1 Workforce Shortages and Low Public-Payer Provider Participation
  • 4.3.2 Ghost Networks, Prior Authorization Friction, and Parity Compliance Gaps
  • 4.3.3 Medicaid Eligibility Churn and Supplemental-Payment Volatility
  • 4.3.4 Safety-Net Facility Closures in Residential and Higher-Acuity Settings
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Industry Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Treatment Modality
  • 5.1.1 Ambulatory Visits
  • 5.1.2 Prescription Medicines
  • 5.1.3 Other Treatment Services
• 5.2 By Condition Group
  • 5.2.1 Mental Health Conditions
    • 5.2.1.1 Mood Disorders
    • 5.2.1.2 Anxiety Disorders
    • 5.2.1.3 Psychotic Disorders
    • 5.2.1.4 Trauma- and Stressor-Related Disorders
    • 5.2.1.5 Eating Disorders
    • 5.2.1.6 Neurodevelopmental and Behavioral Disorders
  • 5.2.2 Substance Use Disorders
    • 5.2.2.1 Alcohol Use Disorder
    • 5.2.2.2 Opioid Use Disorder
    • 5.2.2.3 Stimulant Use Disorder
    • 5.2.2.4 Cannabis Use Disorder
  • 5.2.3 Co-occurring Mental Health and SUD Conditions
• 5.3 By Site of Care
  • 5.3.1 Outpatient Clinics and Office-Based Care
  • 5.3.2 Partial Hospitalization and Intensive Outpatient Programs
  • 5.3.3 Inpatient Psychiatric Hospitals
  • 5.3.4 Residential Treatment Centers
  • 5.3.5 Others
• 5.4 By Age Cohort
  • 5.4.1 Children
  • 5.4.2 Adolescents
  • 5.4.3 Adults
  • 5.4.4 Geriatric Population

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
  • 6.3.1 Acadia Healthcare Company, Inc.
  • 6.3.2 Behavioral Health Group
  • 6.3.3 Boulder Care
  • 6.3.4 Brightside Health, Inc.
  • 6.3.5 Charlie Health
  • 6.3.6 Eleanor Health
  • 6.3.7 Hazelden Betty Ford Foundation
  • 6.3.8 Headway
  • 6.3.9 LifeStance Health Group, Inc.
  • 6.3.10 Lyra Health, Inc.
  • 6.3.11 Newport Healthcare
  • 6.3.12 Oceans Healthcare
  • 6.3.13 Pyramid Healthcare
  • 6.3.14 Rogers Behavioral Health
  • 6.3.15 Rula Health
  • 6.3.16 Sheppard Pratt
  • 6.3.17 Spring Health
  • 6.3.18 Talkspace, Inc.
  • 6.3.19 Teladoc Health, Inc. / BetterHelp
  • 6.3.20 Universal Health Services, Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment